Dasiglucagon for the Treatment of Insulin-induced Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Meta-analysis

BACKGROUND: The use of conventional glucagon for managing insulin-induced hypoglycemia is obscured by its chemical instability and the need for reconstitution of the lyophilized powder, leading to delayed rescue. Dasiglucagon, a glucagon analog, may potentially overcome these shortcomings. AIMS: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Maji, Shampa, Mohanty, Rashmi Ranjan, Maiti, Rituparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613743/
https://www.ncbi.nlm.nih.gov/pubmed/37735694
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-7-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613743/
https://www.ncbi.nlm.nih.gov/pubmed/37735694
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-7-84

Ejemplares similares